Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Appeals Court Backs Broad Institute in Crispr Case

Crispr genome edits illustration

A U.S. appeals court supported the Broad Institute’s claims it invented a separate Crispr technology from University of California, affirming a previous U.S. patent office ruling. . . . → Read More: Appeals Court Backs Broad Institute in Crispr Case

Infographic – Google A.I. Patents Lead Other Tech Companies

Google A.I. patents

According to a new report, Alphabet, the company formerly known as Google, is leading other big tech companies in patent activity for artificial intelligence applications. . . . → Read More: Infographic – Google A.I. Patents Lead Other Tech Companies

Baby Box Technology for Sick Newborns Licensed to Start-Up

Newborn in incubator

A start-up company is gaining the rights to a technology that helps the breathing of infants suffering from withdrawal from drugs taken by their mothers, and other disruptive conditions. . . . → Read More: Baby Box Technology for Sick Newborns Licensed to Start-Up

Pfizer, Biotech Partner on RNA Flu Vaccine

3-D print of influenza virus

A biotechnology company in Germany and drug maker Pfizer are developing a vaccine to prevent seasonal influenza using messenger RNA that instructs cells on production of proteins. . . . → Read More: Pfizer, Biotech Partner on RNA Flu Vaccine

Ultra-Sensitive Nanotech Robot Skin Receives Patent

ultra-sensitive robot skin

Inventors of a system of sensors packaged in a thin film received a patent for their work that enables robotic devices to better sense conditions in the nearby environment. . . . → Read More: Ultra-Sensitive Nanotech Robot Skin Receives Patent

Start-Up Developing Regenerative Liver Disease Treatments

Damaged liver cells

A new enterprise founded by scientists, is underway developing treatments for advanced liver disorders that combine new drugs with cell and gene therapies to restore or replace liver functions. . . . → Read More: Start-Up Developing Regenerative Liver Disease Treatments

Allergan Licensing Crispr for Inherited Eye Disease

Editing DNA

Drug maker Allergan is acquiring the rights from Editas Medicine to develop an application of the genome-editing technology Crispr for the inherited eye disease Leber congenital amaurosis type 10. . . . → Read More: Allergan Licensing Crispr for Inherited Eye Disease

Univ. Spin-Off Developing Myelin Disease Treatments Unveiled

Neurons

A spin-off enterprise from Case Western Reserve University is developing therapies designed to restore the myelin sheath around nerve cells destroyed in multiple sclerosis and other neurological disorders. . . . → Read More: Univ. Spin-Off Developing Myelin Disease Treatments Unveiled

Merck, Biopharma Partner on Cell-Free Immune System Therapies

Cancer magnified

Drug maker Merck is acquiring the rights to therapies for cancer and autoimmune disorders based on a technology for developing synthetic proteins from a process that bypasses live cells. . . . → Read More: Merck, Biopharma Partner on Cell-Free Immune System Therapies

Exosome Technology Acquired for TBI, Stroke Therapies

Stroke circulation

A company developing therapies for brain injuries and neurodegenerative disorders is acquiring the rights to a process that treats these conditions with pieces of RNA transferred in tiny containers call exosomes. . . . → Read More: Exosome Technology Acquired for TBI, Stroke Therapies